Clinical Trials Browser

INDUSTRY × sargramostim × CNS × Clear all

NCT01903330 2025-03-05

ERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma Multiforme

Phase 2 Active not recruiting

Glioblastoma, Gliosarcoma

NCT02149225 2018-08-07

GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients

Phase 1 Completed

Glioblastoma

NCT00458601 2018-01-16

ACT III

Phase 2 Completed

Glioma

NCT01480479 2018-01-16

ACT IV

Phase 3 Completed

Brain Neoplasms, Glioblastoma, Neoplasms, Gliosarcoma